Navigation Links
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
Date:9/22/2011

NEW YORK, Sept. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets

http://www.reportlinker.com/p0619260/Contract-Pharmaceutical-Manufacturing-Research-and-Packaging-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

REPORT HIGHLIGHTS

* The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

* Contract manufacturing of OTC and nutritional products worldwide reached at $114.8 billion in 2010, it will further grow to $127.9 billion in 2011 and is projected to reach at $214.5 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.9%.

* Contract manufacturing of bulk and dosage form drugs worldwide reached at $48.6 billion in 2010, it will further grow to $53.4 billion in 2011 and is projected to reach at $86.3 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.1%.

STUDY OBJECTIVE

The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets. The study provides a global as well as a regionally specific market overview. The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.

The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets. In addition, it discusses company and market strategies to further enhance the market. The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers. The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing. The report highlights the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry. Regulatory requirements and new developments in the market are also discussed in the report.

The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region. Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms. Sales analyses were also performed on revenues gained from contract packaging and contract research. The sales figures discussed are for the examined period of 2009 to 2011. Sales figures were also forecast for the following 5-year period from 2011 through 2016.

Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.

REASONS FOR DOING THIS STUDY

The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services. To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies. This study discusses the different types of contracting companies, their roles, and the share of the market they claim. New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets.

Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies. The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers. The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry. Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.

INTENDED AUDIENCE

This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

CHAPTER ONE: INTRODUCTION 1

STUDY OBJECTIVE 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 3

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 4

DISCLAIMER 4

CHAPTER TWO: SUMMARY 5

SUMMARY 5

SUMMARY (CONTINUED) 6

SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, THROUGH 2016 ($ BILLIONS) 7

SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT

MANUFACTURING AND CONTRACT RESEARCH

ORGANIZATIONS REVENUE, 2009-2016 ($ BILLIONS) 7

CHAPTER THREE: OVERVIEW 8

DEFINITIONS 8

DEFINITIONS (CONTINUED) 9

HISTORY OF OUTSOURCING 10

TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF

OUTSOURCING 10

TABLE 1 (CONTINUED) 11

CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING 12

TYPES OF CONTRACT MANUFACTURERS 12

CONTRACT MANUFACTURING TRAITS 12

REQUIREMENT 12

ABILITY TO BE FLEXIBLE 13

CAPABILITIES WITHOUT COST 13

ADVANTAGES AND DISADVANTAGES OF CONTRACT

MANUFACTURING 13

TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING 14

TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING 14

SELECTING A CONTRACT MANUFACTURER 14

TABLE 4 KEY FACTORS IN SELECTING A CONTRACT

MANUFACTURER 15

TABLE 4 (CONTINUED) 16

ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING 16

LOCATION AND PROXIMITY 16

AFTER-SALES SUPPORT 16

CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH 17

OVERVIEW OF CONTRACT RESEARCH 17

SERVICES OFFERED BY CONTRACT RESEARCH

ORGANIZATIONS 18

TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS 18

TABLE 5 (CONTINUED) 19

SELECTING A CONTRACT RESEARCH ORGANIZATION 19

TABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT

RESEARCH ORGANIZATION 19

TABLE 6 (CONTINUED) 20

RESEARCH PROVIDED BY CONTRACT RESEARCH

ORGNIZATIONS 20

TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT

RESEARCH ORGANIZATIONS 20

TABLE 7 (CONTINUED) 21

CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING 22

NEEDING A CONTRACT PACKAGER 22

TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER 22

TABLE 8 (CONTINUED) 23

SELECTING A CONTRACT PACKAGER 23

TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT

PACKAGER 24

HIRING A CONTRACT PACKAGER 24

TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER 25

TYPES OF PACKAGING 25

TYPES OF PACKAGING (CONTINUED) 26

CHAPTER SEVEN: PROJECT MANAGEMENT 27

SPECIFICATIONS OF PROJECT MANAGEMENT 27

TABLE 11 STEPS OF PROJECT MANAGEMENT 27

TABLE 11 (CONTINUED) 28

PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 PROCESSES OF PROJECT MANAGEMENT 28

TABLE 12 (CONTINUED) 29

FACTORS INVOLVED 29

ROLE OF THE PROJECT MANAGER 29

TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS 30

TECHNOLOGY TRANSFER 30

TABLE 14 TECHNOLOGY TRANSFER STEPS 31

CHAPTER EIGHT: REGULATORY ASPECTS 32

REGULATORY ASPECTS 32

TABLE 15 REGULATED FACTORS OF CMO'S AND CRO'S 33

TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT

MANUFACTURING 33

TABLE 16 (CONTINUED) 34

TABLE 16 (CONTINUED) 35

WARNING LETTERS 36

TABLE 17 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2010 36

TABLE 18 WARNING LETTERS ISSUED TO CONTRACT

MANUFACTURERS, 2009 37

REGULATORY APPROVALS 37

TABLE 19 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, JANUARY THROUGH

MARCH, 2011 38

TABLE 20 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2010 38

TABLE 20 (CONTINUED) 39

TABLE 21 REGULATORY APPROVALS OF CONTRACT

MANUFACTURERS AND FACILITIES, 2009 39

TABLE 21 (CONTINUED) 40

CHAPTER NINE: INDUSTRY STRUCTURE FOR NORTH AMERICA 41

MARKET SHARE OF INDUSTRY LEADERS 41

CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 41

TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN NORTH

AMERICA, 2010 (%) 41

TABLE 22 (CONTINUED) 42

FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN NORTH

AMERICA, 2010 (%) 42

CONTRACT MANUFACTURERS OF SOLID-DOSAGE FORMS 42

TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH

AMERICA, 2010 (%) 43

FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH

AMERICA, 2010 (%) 43

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 44

NONSTERILE 44

TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN NORTH AMERICA, 2010 (%) 44

FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN NORTH AMERICA, 2010 (%) 45

STERILE 45

TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

NORTH AMERICA, 2010 (%) 46

FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

NORTH AMERICA, 2010 (%) 46

CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS 46

TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

NORTH AMERICA, 2010 (%) 47

FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

NORTH AMERICA, 2010 (%) 47

CONTRACT RESEARCH COMPANIES 48

TABLE 27 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN NORTH AMERICA, 2010 (%) 48

FIGURE 6 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN NORTH AMERICA, 2010 (%) 49

CONTRACT PACKAGING COMPANIES 49

TABLE 28 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN NORTH AMERICA 2010 (%) 50

FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN NORTH AMERICA, 2010 (%) 50

CHAPTER TEN: INDUSTRY STRUCTURE FOR EUROPE 51

MARKET SHARE OF INDUSTRY LEADERS 51

CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 51

TABLE 29 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN EUROPE, 2010

(%) 51

TABLE 29 (CONTINUED) 52

FIGURE 8 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN EUROPE, 2010

(%) 52

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 52

TABLE 30 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN EUROPE,

2010 (%) 53

FIGURE 9 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN EUROPE,

2010 (%) 53

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 54

NONSTERILE 54

TABLE 31 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN EUROPE, 2010 (%) 54

FIGURE 10 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN EUROPE, 2010 (%) 55

STERILE 55

TABLE 32 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

EUROPE, 2010 (%) 56

FIGURE 11 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

EUROPE, 2010 (%) 56

CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS 57

TABLE 33 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

EUROPE, 2010 (%) 57

FIGURE 12 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN

EUROPE, 2010 (%) 57

CONTRACT RESEARCH COMPANIES 58

TABLE 34 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN EUROPE, 2010 (%) 58

FIGURE 13 MARKET SHARE OF CONTRACT RESEARCH

COMPANIES, IN EUROPE, 2010 (%) 59

TABLE 35 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN EUROPE, 2010 (%) 60

FIGURE 14 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN EUROPE, 2010 (%) 60

CHAPTER ELEVEN: INDUSTRY STRUCTURE FOR EMERGING

MARKETS 61

MARKET SHARE OF INDUSTRY LEADERS 61

CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 61

TABLE 36 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF

WORLD, 2010 (%) 62

FIGURE 15 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF

WORLD, 2010 (%) 62

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 63

TABLE 37 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, 2010 (%) 63

FIGURE 16 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SOLID DOSAGE FORMS, IN REST OF

WORLD, 2010 (%) 64

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 64

NONSTERILE 64

TABLE 38 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN REST OF WORLD, 2010 (%) 65

FIGURE 17 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,

IN REST OF WORLD, 2010 (%) 65

STERILE 66

TABLE 39 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

REST OF WORLD, 2010 (%) 66

FIGURE 18 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN

REST OF WORLD, 2010 (%) 67

CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS 67

TABLE 40 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST

OF WORLD, 2010 (%) 68

FIGURE 19 MARKET SHARE OF CONTRACT MANUFACTURING

COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST

OF WORLD, 2010 (%) 68

CONTRACT RESEARCH COMPANIES 68

TABLE 41 MARKET SHARES OF CONTRACT RESEARCH

COMPANIES, IN REST OF WORLD, 2010 (%) 69

FIGURE 20 MARKET SHARES OF CONTRACT RESEARCH

COMPANIES, IN REST OF WORLD, 2010 (%) 69

CONTRACT PACKAGING COMPANIES 70

TABLE 42 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN REST OF WORLD, 2010 (%) 70

FIGURE 21 MARKET SHARE OF CONTRACT PACKAGING

COMPANIES, IN REST OF WORLD, 2010 (%) 71

TYPES OF CONTRACT MANUFACTURING AND RESEARCH

FIRMS 71

TABLE 43 SERVICES PROVIDED BY CONTRACT MANUFACTURING

AND RESEARCH FIRMS 72

TABLE 43 (CONTINUED) 73

TABLE 44 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS

BY PACKAGING TYPE 74

CHAPTER TWELVE: TECHNOLOGY TRANSFER 75

REASONS FOR TECHNOLOGY TRANSFER 75

CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER 76

TECHNOLOGY TRANSFER 77

STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER 77

TYPES OF CONTRACTUAL AGREEMENTS USED IN

TECHNOLOGY TRANSFER 78

CONFIDENTIAL DISCLOSURE AGREEMENT (CDA) 79

MATERIAL TRANSFER AGREEMENT (MTA) 79

ASSIGNMENT DEED 79

LICENSE AGREEMENT 80

CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS 80

CHARACTERISTICS OF A SUCCESSFUL PROJECT 80

CHARACTERISTICS OF A SUCCESSFUL … (CONTINUED) 81

CHAPTER THIRTEEN: NEW DEVELOPMENTS 82

LONZA 82

ABBOTT 83

HOSPIRA 84

COVIDIEN 84

OTHER 85

OTHER (CONTINUED) 86

CHAPTER FOURTEEN: MARKET ANALYSIS FOR NORTH AMERICA 87

CONTRACT MANUFACTURING 87

CONTRACT MANUFACTURE OF BULK DRUGS/API'S 87

Market Overview 87

Market Revenue 88

TABLE 45 BULK DRUG/API CONTRACT MANUFACTURING, FOR

NORTH AMERICA, THROUGH 2016 ($ BILLIONS) 89

FIGURE 22 BULK DRUG/API CONTRACT MANUFACTURING, FOR

NORTH AMERICA, 2009-2016 ($ BILLIONS) 89

CONTRACT MANUFACTURE OF DOSAGE FORMULATIONS 89

Solid Dosage Formulations 90

Market Overview 90

Market Revenue 91

TABLE 46 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR NORTH AMERICA, THROUGH 2016 ($ BILLIONS) 92

FIGURE 23 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR NORTH AMERICA, 2009-2016 ($ BILLIONS) 92

Market by Formulation 92

Market Revenue 93

TABLE 47 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR NORTH AMERICA,

THROUGH 2016 ($ BILLIONS) 93

FIGURE 24 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATIONS, FOR NORTH AMERICA, 2009-

2016 ($ BILLIONS) 94

TABLE 48 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA,

2010 (%) 94

FIGURE 25 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATIONS, FOR NORTH AMERICA,

2010 (%) 95

Liquid Dosage Formulation 95

Market Overview 95

Market Revenue 96

Nonsterile Formulations 96

TABLE 49 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($

MILLIONS) 97

FIGURE 26 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR NORTH AMERICA, 2009-2016 ($

MILLIONS) 97

Sterile Formulations 97

TABLE 50 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($

MILLIONS) 98

FIGURE 27 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($

MILLIONS) 98

Market by Formulation 98

Nonsterile Formulations 98

TABLE 51 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, THROUGH 2016 ($ MILLIONS) 99

FIGURE 28 LIQUID DOSAGE FORM (NON STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, 2009-2016 ($ MILLIONS) 100

TABLE 52 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 100

FIGURE 29 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 101

Sterile Formulations 101

TABLE 53 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, THROUGH 2016 ($ MILLIONS) 102

FIGURE 30 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, 2009-2016 ($ MILLIONS) 102

TABLE 54 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 103

FIGURE 31 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 103

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS 103

Market Overview 103

Market Revenue 104

TABLE 55 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($

MILLIONS) 104

FIGURE 32 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR NORTH AMERICA, 2009-2016 ($

MILLIONS) 105

TABLE 56 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, THROUGH 2016 ($ MILLIONS) 106

FIGURE 33 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, 2009-2016 ($ MILLIONS) 106

TABLE 57 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 107

FIGURE 34 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 107

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS 107

Market Overview 108

TABLE 58 CONTRACTING COMPANIES PROVIDING DRUGDELIVERY

SYSTEMS 109

Market Revenue 110

TABLE 59 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR NORTH AMERICA,

THROUGH 2016 ($ BILLIONS) 110

FIGURE 35 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR NORTH AMERICA,

THROUGH 2016 ($ BILLIONS) 110

Market by Formulation 111

TABLE 60 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH

AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY

FORMULATION, THROUGH 2016 ($ MILLIONS) 112

FIGURE 36 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH

AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY

FORMULATIONS, 2009-2016 ($ MILLIONS) 112

Market Share 113

TABLE 61 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH

AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE,

BY FORMULATION, 2010 (%) 113

FIGURE 37 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH

AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE,

BY FORMULATIONS, 2010 (%) 114

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS 114

Market Overview 115

Market Revenue 116

TABLE 62 OTC AND NUTRITIONAL PRODUCT REVENUE FOR

NORTH AMERICA BY CONTRACT MANUFACTURING, THROUGH

2016 ($ BILLIONS) 116

FIGURE 38 OTC AND NUTRITIONAL PRODUCT REVENUE FOR

NORTH AMERICA BY CONTRACT MANUFACTURING, 2009-2016

($ BILLIONS) 116

Market by Formulation 117

TABLE 63 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE BY FORMULATION FOR NORTH

AMERICA, THROUGH 2016 ($ BILLIONS) 117

FIGURE 39 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH

AMERICA, 2009-2016 ($ BILLIONS) 118

Market Shares 118

TABLE 64 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

NORTH AMERICA, 2010 (%) 118

FIGURE 40 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

NORTH AMERICA, 2010 (%) 119

CONTRACT RESEARCH 119

MARKET OVERVIEW 119

Partnerships 120

Expansions of Facilities 120

MARKET REVENUE 120

TABLE 65 CONTRACT RESEARCH REVENUE FOR NORTH

AMERICA, THROUGH 2016 ($ BILLIONS) 121

FIGURE 41 CONTRACT RESEARCH REVENUE, FOR NORTH

AMERICA, 2009-2016 ($ BILLIONS) 121

Market by Discipline 121

TABLE 66 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

NORTH AMERICA, THROUGH 2016 ($ BILLIONS) 122

FIGURE 42 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

NORTH AMERICA, 2009-2016 ($ BILLIONS) 122

Market Shares by Discipline 123

TABLE 67 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR NORTH AMERICA, 2010 (%) 123

FIGURE 43 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR NORTH AMERICA, 2010 (%) 123

CONTRACT PACKAGING 124

MARKET OVERVIEW 124

Market Revenue 124

TABLE 68 CONTRACT PACKAGING REVENUE, FOR NORTH

AMERICA, THROUGH 2016 ($ BILLIONS) 125

FIGURE 44 CONTRACT PACKAGING REVENUE, FOR NORTH

AMERICA, 2009-2016 ($ BILLIONS) 125

Market by Package Type 126

TABLE 69 CONTRACT PACKAGING REVENUE BY TYPE, FOR

NORTH AMERICA, THROUGH 2016 ($ MILLIONS) 127

FIGURE 45 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

NORTH AMERICA, 2009-2016 ($ MILLIONS) 127

Market Share by Type 128

TABLE 70 CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR

NORTH AMERICA, 2010 (%) 128

FIGURE 46 CONTRACT PACKAGING MARKET SHARE, BY TYPE,

FOR NORTH AMERICA, 2010 (%) 128

CHAPTER FIFTEEN: MARKET ANALYSIS FOR EUROPE 129

CONTRACT MANUFACTURING 129

CONTRACT MANUFACTURE OF BULK DRUGS/API'S 129

Market Overview 129

Market Revenue 130

TABLE 71 BULK DRUG/API CONTRACT MANUFACTURING

REVENUE, FOR EUROPE, THROUGH 2016 ($ BILLIONS) 130

FIGURE 47 BULK DRUG/API CONTRACT MANUFACTURING

REVENUE, FOR EUROPE, 2009-2016 ($ BILLIONS) 131

CONTRACT MANUFACTURE OF ORAL DOSAGE

FORMULATIONS 131

Solid Dosage Formulations 132

Market Overview 132

Market Revenue 133

TABLE 72 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR EUROPE, THROUGH 2016 ($ BILLIONS) 133

FIGURE 48 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR EUROPE, 2009- 2016 ($ BILLIONS) 134

Market by Formulation 134

Market Revenue 135

TABLE 73 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 135

FIGURE 49 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($

BILLIONS) 136

TABLE 74 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATION, FOR EUROPE, 2010 (%) 136

FIGURE 50 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARES, BY FORMULATIONS, FOR EUROPE, 2010 (%) 137

Liquid Dosage Formulation 137

Market Overview 137

Market Revenue 138

Nonsterile Formulations 138

TABLE 75 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 139

FIGURE 51 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 139

Sterile Formulations 139

TABLE 76 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 140

FIGURE 52 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 140

Market by Formulation 140

Nonsterile Formulations 140

TABLE 77 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 141

FIGURE 53 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 142

TABLE 78 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES, BY FORMULATION, FOR

EUROPE, 2010 (%) 142

FIGURE 54 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 143

Sterile Formulations 143

TABLE 79 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 144

FIGURE 55 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

2009-2016 ($ MILLIONS) 144

TABLE 80 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 145

FIGURE 56 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 145

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS 145

Market Overview 145

Market Revenue 146

TABLE 81 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS) 147

FIGURE 57 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS) 147

TABLE 82 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 148

FIGURE 58 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 148

TABLE 83 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 149

FIGURE 59 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 149

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS 149

Market Overview 150

TABLE 84 CONTRACTING COMPANIES PROVIDING DRUG

DELIVERY SYSTEMS 151

Market Revenue 151

TABLE 85 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 152

FIGURE 60 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, 2009-2016 ($

BILLIONS) 152

Market by Formulation 152

TABLE 86 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ MILLIONS) 153

FIGURE 61 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ MILLIONS) 154

Market Share 154

TABLE 87 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 155

FIGURE 62 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 155

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS 156

Market Revenue 157

TABLE 88 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, THROUGH 2016 ($

BILLIONS) 157

FIGURE 63 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY

CONTRACT MANUFACTURING, FOR EUROPE, 2009-2016 ($

BILLIONS) 157

Market by Formulation 158

TABLE 89 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 158

FIGURE 64 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR

EUROPE, 2009-2016 ($ BILLIONS) 159

Market Shares 159

TABLE 90 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

EUROPE, 2010 (%) 159

FIGURE 65 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR

EUROPE, 2010 (%) 160

CONTRACT RESEARCH 160

MARKET OVERVIEW 160

Partnerships 160

Expansions of Facilities 161

Market Revenue 161

TABLE 91 CONTRACT RESEARCH REVENUE, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 162

FIGURE 66 CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-

2016 ($ BILLIONS) 162

Market by Discipline 162

TABLE 92 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 163

FIGURE 67 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, 2009-2016 ($ MILLIONS) 163

Market Share by Discipline 163

TABLE 93 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR EUROPE, 2010 (%) 164

FIGURE 68 CONTRACT RESEARCH MARKET SHARE, BY

DISCIPLINE, FOR EUROPE, 2010 (%) 164

CONTRACT PACKAGING 165

MARKET OVERVIEW 165

Market Revenue 165

TABLE 94 CONTRACT PACKAGING REVENUE, FOR EUROPE,

THROUGH 2016 ($ BILLIONS) 166

FIGURE 69 CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-

2016 ($ BILLIONS) 166

Market by Package Type 166

TABLE 95 CONTRACT PACKAGING REVENUE BY TYPE, FOR

EUROPE, THROUGH 2016 ($ MILLIONS) 167

FIGURE 70 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

EUROPE, 2009-2016 ($ BILLIONS) 168

Market Share by Type 168

TABLE 96 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR

EUROPE, 2010 (%) 169

FIGURE 71 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR

EUROPE, 2010 (%) 169

CHAPTER SIXTEEN: MARKET ANALYSIS FOR REST OF

WORLD/EMERGING MARKETS 170

CONTRACT MANUFACTURING 170

CONTRACT MANUFACTURE OF BULK DRUGS/API'S 170

Market Overview 170

Market Revenue 171

TABLE 97 REST OF WORLD BULK DRUG/API'S CONTRACT

MANUFACTURING REVENUE, THROUGH 2016 ($ BILLIONS) 172

FIGURE 72 REST OF WORLD BULK DRUG/API'S CONTRACT

MANUFACTURING REVENUE, 2009-2016 ($ BILLIONS) 172

CONTRACT MANUFACTURE OF ORAL DOSAGE

FORMULATIONS 172

Solid Dosage Formulations 173

Market Overview 173

Market Revenue 174

TABLE 98 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS) 174

FIGURE 73 SOLID DOSAGE FORM CONTRACT MANUFACTURING,

FOR REST OF WORLD, 2009-2016 ($ BILLIONS) 175

Market by Formulation 175

Market Revenue 175

TABLE 99 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 176

FIGURE 74 SOLID DOSAGE FORM CONTRACT MANUFACTURING

REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016

($ BILLIONS) 176

TABLE 100 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE, BY FORMULATION, FOR REST OF WORLD,

2010 (%) 177

FIGURE 75 SOLID DOSAGE FORM CONTRACT MANUFACTURING

MARKET SHARE BY FORMULATION, FOR REST OF WORLD, 2010

(%) 177

Liquid Dosage Formulation 178

Market Overview 178

Market Revenue 178

Nonsterile Formulations 178

TABLE 101 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 179

FIGURE 76 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 179

Sterile Formulations 180

TABLE 102 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 180

FIGURE 77 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 180

Market by Formulation 181

Nonsterile Formulations 181

TABLE 103 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 181

FIGURE 78 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 182

TABLE 104 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 182

FIGURE 79 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 183

Sterile Formulations 183

TABLE 105 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE BY FORMULATION FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 184

FIGURE 80 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 184

TABLE 106 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 185

FIGURE 81 LIQUID DOSAGE FORM (STERILE) CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 185

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE

FORMULATIONS 185

Market Overview 185

Market Revenue 186

TABLE 107 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($

MILLIONS) 187

FIGURE 82 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($

MILLIONS) 187

Market by Formulation 187

TABLE 108 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 188

FIGURE 83 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING REVENUE BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 188

TABLE 109 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 189

FIGURE 84 SEMISOLID DOSAGE FORM CONTRACT

MANUFACTURING MARKET SHARE BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 189

CONTRACT MANUFACTURE OF ADVANCED DRUG

DELIVERY PRODUCTS 189

Market Overview 190

TABLE 110 CONTRACTING COMPANIES PROVIDING DRUG

DELIVERY SYSTEMS IN ROW 191

TABLE 111 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 191

FIGURE 85 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 192

Market by Formulation 192

TABLE 112 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ MILLIONS) 193

FIGURE 86 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, 2009-2016 ($ MILLIONS) 193

Market Share 194

TABLE 113 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 194

FIGURE 87 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 195

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL

PRODUCTS 195

Market Revenue 196

TABLE 114 OTC AND NUTRITIONAL PRODUCTS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD,

THROUGH 2016 ($ BILLIONS) 197

FIGURE 88 OTC AND NUTRITIONAL PRODUCTS REVENUE BY

CONTRACT MANUFACTURING, FOR REST OF WORLD, 2009-2016

($ BILLIONS) 197

TABLE 115 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF

WORLD, THROUGH 2016 ($ BILLIONS) 198

FIGURE 89 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING REVENUE, BY FORMULATIONS, FOR REST

OF WORLD, 2009-2016 ($ BILLIONS) 199

Market Shares 199

TABLE 116 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2010 (%) 199

FIGURE 90 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT

MANUFACTURING MARKET SHARE, BY FORMULATION, FOR

REST OF WORLD, 2009-2016 (%) 200

CONTRACT RESEARCH 200

MARKET OVERVIEW 200

Partnerships 200

Expansions of Facilities 201

Market Revenue 202

TABLE 117 CONTRACT RESEARCH REVENUE FOR REST OF

WORLD, THROUGH 2016 ($ BILLIONS) 202

FIGURE 91 CONTRACT RESEARCH REVENUE FOR REST OF

WORLD, 2009-2016 ($ BILLIONS) 203

Market by Discipline 203

TABLE 118 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

REST OF WORLD, THROUGH 2016 ($ BILLIONS) 204

FIGURE 92 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR

REST OF WORLD, 2009-2016 ($ BILLIONS) 204

Market Shares by Discipline 205

TABLE 119 CONTRACT RESEARCH MARKET SHARE BY

DISCIPLINE, FOR REST OF WORLD, 2010 (%) 205

FIGURE 93 CONTRACT RESEARCH MARKET SHARE BY

DISCIPLINE, FOR REST OF WORLD, 2010 (%) 205

CONTRACT PACKAGING 206

MARKET OVERVIEW 206

TABLE 120 CONTRACT PACKAGING REVENUE, FOR REST OF

WORLD, THROUGH 2016 ($ BILLIONS) 207

FIGURE 94 CONTRACT PACKAGING REVENUE, FOR REST OF

WORLD, 2009-2016 ($ BILLIONS) 207

Market by Package Type

To order this report:

Manufacturing Industry: Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets

Manufacturing Business News

More  Industry Analysis and Insights

__________________________

Contact Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America
2. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe
3. Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients
4. Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management
5. Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection
6. Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytrens Contracture in E-poster at ASSH Meeting
7. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
8. Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application
9. China Contract Research Organization (CRO) Industry Report, 2010-2011
10. Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veterans Administration
11. Pharmaceutical Contract Manufacturing and API Sourcing in Central Europe and the Balkan States 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):